Clarification On Movement In Price
Filed with BSE · · 1 page · English
Summary by 6ix AI
Vanta Bioscience Ltd. has issued a clarification regarding the movement in its share price, responding to an inquiry from BSE Ltd. The company stated that it has disclosed all material information related to its operations and performance as required by regulations. Vanta Bioscience emphasized that it is unaware of the reasons behind any significant price movements, attributing them to market dynamics. The management reassured that they will continue to comply with all necessary regulations and laws.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
We hereby further submit that we are not aware of the reason of significant movement, if any, in the price of our shares. The movement in the share price is purely market driven. The management of the company is in no way connected with the movement in the price of the shares. We would like to reiterate that the Company has always and will continue to adhere to the compliances required under the L
Earlier from Vanta Bioscience
- Vanta Bioscience Ltd. Press Release Nov 14 2025
- Financial Results For The Half Year Ended September 30, 2025
- Board Meeting Outcome for Outcome Of The Board Meeting Held On November 14, 2025
- Vanta Bioscience Ltd. Press Release Nov 01 2025
- Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Later from Vanta Bioscience
- Closure of Trading Window
- Vanta Bioscience Ltd. Press Release Mar 24 2026
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Vanta Bioscience Ltd. Press Release Apr 10 2026
- Board Meeting Intimation for Approval Of Standalone And Consolidated Audited Financial Results For The Half Year And Financial Year Ended March 31, 2026 - Board Meeting To Be Held On May 30, 2026
Follow Vanta Bioscience into a list and get an email when it puts out news.
Follow Vanta Bioscience